Leonteq Securities’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,700
Closed -$72.7K – 1376
2026
Q2
$72.7K Hold
5,700
– – ﹤0.01% 741
2026
Q1
$78.4K Hold
5,700
– – ﹤0.01% 781
2025
Q4
$89K Buy
5,700
+5,000
+714% +$92.2K ﹤0.01% 826
2025
Q3
$16.9K Buy
+700
New +$26K ﹤0.01% 1058

Other funds holding TNXP

Leonteq Securities's TNXP Position: Q3 2026 in Review

Leonteq Securities sold out of Tonix Pharmaceuticals (TNXP) in Q3 2026, closing a stake of 5,700 shares — an estimated $72.7K sold.

Leonteq Securities first reported a position in TNXP in Q3 2025 and held it in 4 quarters. The position peaked at $89K in Q4 2025. 76 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Leonteq Securities reported no remaining Tonix Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Leonteq Securities sold 5,700 Tonix Pharmaceuticals shares in Q3 2026, an estimated $72.7K.
  • Leonteq Securities first reported a position in Tonix Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Leonteq Securities's Tonix Pharmaceuticals position peaked at $89K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.